All In Biotech

Investigational drug · Phase 3

LNK01001

Not approved by FDA. In 3 industry-sponsored Phase 2 or 3 trials that are active or finished in the last two years, most often for Ankylosing Spondylitis, Atopic Dermatitis, Rheumatoid Arthritis.

Phase 3

Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations

Highest phase

Phase 3

Industry-sponsored trials

Phase 2 and 3 trials

3

1 still active

All registered trials

6

Any phase or sponsor naming "LNK01001"

First trial start

2023

Dec 12, 2023

Sponsors

Lead sponsors of its Phase 2 and 3 trials.

All registered trials by phase

Every ClinicalTrials.gov drug study naming "LNK01001", any sponsor or status.

Conditions studied

As listed on its trial records.

  • Ankylosing Spondylitis
  • Atopic Dermatitis
  • Rheumatoid Arthritis

Approved drugs for the same conditions: Rheumatoid arthritis · Atopic dermatitis (eczema) · Ankylosing spondylitis · Immunology and inflammation · Dermatology

Largest trials

Live from ClinicalTrials.gov: studies naming "LNK01001" as an intervention, largest first.

All trials

Newest research

PubMed records naming it or its code names, newest first.

All 0 on PubMed

No PubMed records name it yet, which is common for early code-named drugs.

Also in development for Ankylosing Spondylitis

  • Jaktinib HydrochloridePhase 34 trials

    Suzhou Zelgen Biopharmaceuticals Co.,Ltd · Atopic Dermatitis, Ankylosing Spondylitis

  • AK111Phase 32 trials

    Akeso · Psoriasis, Skin Diseases, Ankylosing Spondylitis

  • HS_SW01 cellsHS_SW01Phase 23 trials

    Shenzhen Huishan Biotechnology Co., Ltd. · Ankylosing Spondylitis, Primary Ovarian Insufficiency (Poi), Systemic Sclerosis (SSc)

  • vilamakitugXB2001, NatrunixPhase 22 trials

    XBiotech, Inc. · Axial Spondyloarthritis, Ankylosing Spondylitis, r-axSpA

Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.